Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Daniel, Peter Prof. Dr. (1) Daumke, Oliver Prof. Dr. (8) Dechend, Ralf Priv. Doz. (1) Fälber, Katja Dr. (1) Geisberger, Sabrina Yasmin Dr. (1) Haucke, Volker Professor (2) Heinemann, Udo Prof. Dr. (1) Hinz, Michael Dr. (1) Kammertöns, Thomas Dr. (4) Landthaler, Markus Prof. Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (2) Müller, Dominik Prof. Dr. (1) Müller, Gerd Dr. (1) Pezzutto, Antonio Prof. Dr. (3) Schlegel, Jeanette (1) Schütz, Anja Dr. (1) Siffrin, Volker (1) Uckert, Wolfgang Prof. Dr. (3) Willimsky, Gerald Dr. (3) Yilmaz, Zekiye Buket Dr. (1) (-) Blankenstein, Thomas Prof. Dr. (14) (-) Höpken, Uta Elisabeth PD Dr. (1) (-) Kopp, Joachim Dr. (1) Advanced Light Microscopy (1) Biologie maligner Lymphome (8) Immunregulation und Krebs (1) Mikroumgebung als Regulator bei Autoimmunität und Krebs (8) (-) Molekulare Immunologie und Gentherapie (14) Proteom Dynamik (1) RNA Biologie und Posttranscriptionale Regulation (1) (-) Strukturbiologie Membran-assoziierter Prozesse (1) Systembiologie von Gen-regulatorischen Elementen (4) Translationale Tumorimmunologie (1) Zellzustände und ihre Funktionsweisen (1) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) (-) 2000 (8) 2001 (5) 2002 (5) 2003 (9) 2004 (8) 2005 (10) 2006 (1) 2007 (5) 2008 (5) 2009 (2) 2010 (7) 2011 (5) 2012 (7) 2013 (12) (-) 2014 (3) (-) 2015 (4) 2016 (4) 2017 (6) 2018 (5) 2019 (7) 2021 (4) 2022 (6) 2023 (6) 2024 (2) 15 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Höpken, Uta Elisabeth PD Dr.Kopp, Joachim Dr.Molekulare Immunologie und Gentherapie Strukturbiologie Membran-assoziierter Prozesse200020142015 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. April 2015 / Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber 01. April 2015 / Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein 01. August 2015 / Mol Oncol Potent anti-tumor response by targeting B cell maturation antigen (BCMA) in a mouse model of multiple myeloma F. Oden S.F. Marino J. Brand S. Scheu C. Kriegel D. Olal A. Takvorian J. Westermann B. Yilmaz M. Hinz O. Daumke U.E. Höpken G. Müller M. Lipp 15. April 2015 / Int J Cancer Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κB A. Flörcken M. Grau A. Wolf A. Weilemann J. Kopp B. Dörken T. Blankenstein A. Pezzutto P. Lenz G. Lenz J. Westermann 01. Dezember 2014 / Canc Res Efficacy of CAR T-cell therapy in large tumors relies upon stromal targeting by IFNγ A. Textor J.J. Listopad L.L. Wührmann C. Perez A. Kruschinski M. Chmielewski H. Abken T. Blankenstein J. Charo 01. September 2014 / Eur J Immunol Misinitiation of intrathymic MART-1 transcription and biased TCR usage explain the high frequency of MART-1-specific T cells S. Pinto D. Sommermeyer C. Michel S. Wilde D. Schendel W. Uckert T. Blankenstein B. Kyewski 01. Februar 2000 / Canc Res Interleukin-7/B7.1-encoding adenoviruses induce rejection of transplanted but not nontransplanted tumors G. Willimsky T. Blankenstein 01. Januar 2000 / Hum Gene Ther Efficient gene transfer into primary human CD8+ T lymphocytes by MuLV-10A1 retrovirus pseudotype W. Uckert C. Becker M. Gladow D. Klein T. Kammertoens L. Pedersen T. Blankenstein 01. Juni 2000 / Immunity CD4+ T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFNgamma receptor expression by nonhematopoietic cells Z.H. Qin T. Blankenstein 01. Mai 2000 / Bone Marrow Transplant Bcr/abl+ autologous dendritic cells for vaccination in chronic myeloid leukemia J. Westermann J. Kopp I. Koerner G. Richter Z. Qin T. Blankenstein B. Doerken A. Pezzutto Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
01. April 2015 / Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber
01. April 2015 / Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein
01. August 2015 / Mol Oncol Potent anti-tumor response by targeting B cell maturation antigen (BCMA) in a mouse model of multiple myeloma F. Oden S.F. Marino J. Brand S. Scheu C. Kriegel D. Olal A. Takvorian J. Westermann B. Yilmaz M. Hinz O. Daumke U.E. Höpken G. Müller M. Lipp
15. April 2015 / Int J Cancer Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κB A. Flörcken M. Grau A. Wolf A. Weilemann J. Kopp B. Dörken T. Blankenstein A. Pezzutto P. Lenz G. Lenz J. Westermann
01. Dezember 2014 / Canc Res Efficacy of CAR T-cell therapy in large tumors relies upon stromal targeting by IFNγ A. Textor J.J. Listopad L.L. Wührmann C. Perez A. Kruschinski M. Chmielewski H. Abken T. Blankenstein J. Charo
01. September 2014 / Eur J Immunol Misinitiation of intrathymic MART-1 transcription and biased TCR usage explain the high frequency of MART-1-specific T cells S. Pinto D. Sommermeyer C. Michel S. Wilde D. Schendel W. Uckert T. Blankenstein B. Kyewski
01. Februar 2000 / Canc Res Interleukin-7/B7.1-encoding adenoviruses induce rejection of transplanted but not nontransplanted tumors G. Willimsky T. Blankenstein
01. Januar 2000 / Hum Gene Ther Efficient gene transfer into primary human CD8+ T lymphocytes by MuLV-10A1 retrovirus pseudotype W. Uckert C. Becker M. Gladow D. Klein T. Kammertoens L. Pedersen T. Blankenstein
01. Juni 2000 / Immunity CD4+ T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFNgamma receptor expression by nonhematopoietic cells Z.H. Qin T. Blankenstein
01. Mai 2000 / Bone Marrow Transplant Bcr/abl+ autologous dendritic cells for vaccination in chronic myeloid leukemia J. Westermann J. Kopp I. Koerner G. Richter Z. Qin T. Blankenstein B. Doerken A. Pezzutto